Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injections for Vulvar Lichen Sclerosus
NCT02794363Completed
- Sponsor
- The Centers for Vulvovaginal Disorders
- Start
- May 2014
- Primary completion
- Jan 2016
- Modality
- Adoptive Cell Transfer
01
Overview
Open-label, single-arm trial of autologous platelet-rich plasma in vulvar lichen sclerosus (LS), sponsored by The Centers for Vulvovaginal Disorders. Primary endpoint: Decrease in inflammation on post treatment biopsies at 14 weeks. Started May 2014; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT02794363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794363.